Literature DB >> 8431618

Maternal noncompliance with antibiotics during breastfeeding.

S Ito1, G Koren, T R Einarson.   

Abstract

OBJECTIVE: To determine the incidence of antibiotic prescription failure in breastfeeding women, and to characterize breastfeeding patterns during antibiotic therapy.
DESIGN: Prospective cohort study by telephone follow-up of 203 breastfeeding women who were prescribed antibiotics as monotherapy.
SETTING: A teratogen/drug information service (the Motherisk Program) in a tertiary care, pediatric hospital in Toronto, Canada. MAIN OUTCOME MEASURES: Number of breastfeeding women who did not initiate the antimicrobial therapy, and breastfeeding patterns during therapy in women who started it.
RESULTS: Of 203 breastfeeding women who consulted the Motherisk Program for information about the safety of antimicrobials during breastfeeding, 125 (62 percent) were followed within 32 weeks (median 11). Nineteen of the 125 (15 percent) did not initiate the antimicrobial therapy. Of the remaining 106 women, 7 (7 percent) stopped breastfeeding during therapy. Despite reassuring advice, 1 in 5 women either did not initiate therapy or did not continue breastfeeding.
CONCLUSIONS: Physicians should be aware of the substantial rate of noncompliance with drug regimens among nursing women and the potential negative impact of drug therapy on breastfeeding.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431618     DOI: 10.1177/106002809302700110

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  10 in total

Review 1.  Antibiotics and breast-feeding: a critical review of the literature.

Authors:  Allison M Chung; Michael D Reed; Jeffrey L Blumer
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Estimated infant exposure to enantiomer-specific methadone levels in breastmilk.

Authors:  Debra L Bogen; James M Perel; Joseph C Helsel; Barbara H Hanusa; Matthew Thompson; Katherine L Wisner
Journal:  Breastfeed Med       Date:  2011-02-24       Impact factor: 1.817

3.  Use, attitudes and knowledge of medications among pregnant women: A Saudi study.

Authors:  Noha M Zaki; Ahmed A Albarraq
Journal:  Saudi Pharm J       Date:  2013-10-23       Impact factor: 4.330

4.  Cesarean delivery as a barrier for breastfeeding initiation: the Puerto Rican experience.

Authors:  Naydi Pérez-Ríos; Gilberto Ramos-Valencia; Ana Patricia Ortiz
Journal:  J Hum Lact       Date:  2008-06-06       Impact factor: 2.219

Review 5.  Pharmacotherapy for depression and bipolar disorder during lactation: A framework to aid decision making.

Authors:  Jennifer Sprague; Katherine L Wisner; Debra L Bogen
Journal:  Semin Perinatol       Date:  2020-01-30       Impact factor: 3.300

6.  Albendazole and its metabolites in the breast milk of lactating women following a single oral dose of albendazole.

Authors:  Ahmed M Abdel-tawab; Mark Bradley; Essam A Ghazaly; John Horton; Maged el-Setouhy
Journal:  Br J Clin Pharmacol       Date:  2009-11       Impact factor: 4.335

7.  Knowledge, attitudes and practices of health professionals and women towards medication use in breastfeeding: A review.

Authors:  Safeera Y Hussainy; Narmin Dermele
Journal:  Int Breastfeed J       Date:  2011-08-26       Impact factor: 3.461

Review 8.  Postpartum women's use of medicines and breastfeeding practices: a systematic review.

Authors:  Moni R Saha; Kath Ryan; Lisa H Amir
Journal:  Int Breastfeed J       Date:  2015-10-28       Impact factor: 3.461

9.  Commentary on the article "Postpartum women's use of medicines and breastfeeding practices: a systematic review".

Authors:  Laurence Spiesser-Robelet; Rémi Gagnayre
Journal:  Int Breastfeed J       Date:  2016-07-21       Impact factor: 3.461

Review 10.  Quantifying breast milk intake by term and preterm infants for input into paediatric physiologically based pharmacokinetic models.

Authors:  Cindy H T Yeung; Simon Fong; Paul R V Malik; Andrea N Edginton
Journal:  Matern Child Nutr       Date:  2020-01-21       Impact factor: 3.092

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.